goserelin and Urinary-Bladder-Neoplasms

Aggressive angiomyxoma is a rare, locally infiltrative tumor, frequently occurring in female patients. Although wide local excision is considered standard therapy, radical surgery may be needed.. A 49-year-old woman presented with an aggressive angiomyxoma involving the vulva and bladder. Given the hormone receptor status and size of the tumor, the patient was initially treated with fulvestrant and goserelin acetate in an attempt to reduce the size of the mass. She was followed up at 1- to 3-month intervals; after 6 months of treatment, owing to increasing size of the mass and worsening symptoms, the decision was made to proceed with radical surgery.. Although a less radical surgical approach is preferred, radical surgery is possible for treatment of aggressive angiomyxoma when needed.

Topics: Antineoplastic Agents, Hormonal; Diagnosis, Differential; Estradiol; Female; Fulvestrant; Goserelin; Humans; Middle Aged; Myxoma; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vulvar Neoplasms